In the context of CLL, we have previously found that overexpression of APRIL in the TCL1 mouse model accelerated disease progression.6 Furthermore APRIL was present in CLL lymph nodes as shown in initial experiments using quantitative PCR and immunohistochemistry. This evidence concerns the gene TNFSF13 and B-cell chronic lymphocytic leukemia.